Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Brostallicin

EU orphan designation number: EU/3/05/336
Active ingredient: Brostallicin
Indication: Treatment of soft tissue sarcoma
Sponsor: Nuvisan Oncology SA
18-20 rue Pasteur, F-94270 Le Kremlin-Bicêtre CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/12/2005 Orphan designation EMEA/OD/071/05 (2005)5971 of 23/12/2005
19/02/2009 Transfer of orphan designation EMEA/OD/071/05/T/01 (2009)1186 of 17/02/2009
30/04/2013 Removal of orphan designation from Community Register
30/04/2013 Change of name and/or address of sponsor